China Injectable Drug Delivery Devices Market Overview
According to SPER Market Research, the China Injectable Drug Delivery Devices Market is estimated to reach USD 235.46 billion by 2032 with a CAGR of 18.23%.
The delivery and transportation of therapeutic medicine to a patient's body is accomplished using injectable devices. The equipment used to deliver injectable drugs comes in a wide variety, including traditional syringes, needle-free injectors, auto-injectors, and pen injectors. Devices for subcutaneous drug delivery are used to treat a variety of chronic and infectious disorders. In this, the medicinal medications are injected using a syringe into the layer between muscles and tissues. Compared to direct injection into veins, absorption happens more slowly.
The market for injectable drug delivery devices is predicted to grow more rapidly in the near future. It is due to the increase in public awareness and significant financial investments in medical infrastructure.
Impact of COVID-19 on the China Injectable Drug Delivery Devices Market
Covid-19 is a highly contagious illness that mostly affects people's respiratory systems. The covid19 is affecting people all throughout the world. With the exception of the pharmaceutical industry, it has had a negative impact on the operation of every industry. There is an increased need for ventilators, testing supplies, medications, vaccines, and oxygen cylinders compared to before the global pandemic. The demand for injectable devices and other healthcare products increased last year, which led to a boom in the market for injectable medication delivery devices. Every country's government devotes a significant portion of its financial resources to acquiring and producing additional pharmaceuticals and medical supplies. People are becoming immunized all throughout the world. The market for injectable medicine delivery methods is growing as a result.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Type of Devices, By Therapeutic Application, By Usage Pattern, By Site of Delivery
|
| Regions covered | North China, Northeast China, East China, South China, Central China, Southwest China, Northwest China.
|
| Companies Covered | Baxter, Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd.
|
China Injectable Drug Delivery Devices Market Segmentation:
1. By Type of Devices:
- Conventional Injection Devices
- Self-Injection Devices
2. By Therapeutic Application:
- Autoimmune Diseases
- Hormonal Disorders
- Cancer
3. By Usage Pattern:
- Curative pattern
- Immunization
4. By Site of Delivery:
- Intramuscular
- Subcutaneous
- Intra Dermal
5. By Region:
- North China
- Northeast China
- East China
- South China 
- Central China
- Southwest China
- Northwest China
Key Topics Covered in the Report:
- Size of China Injectable Drug Delivery Devices Market (FY’2019-FY’2032)
- Overview of China Injectable Drug Delivery Devices Market
- Segmentation of China Injectable Drug Delivery Devices By Type of Devices (Conventional Injection Devices, Self-Injection Devices)
- Segmentation of China Injectable Drug Delivery Devices Market By Therapeutic Application (Autoimmune Diseases, Hormonal Disorders, Cancer)
- Segmentation of China Injectable Drug Delivery Devices Market By Usage Pattern (Curative pattern, Immunization)
- Segmentation of China Injectable Drug Delivery Devices By Site of Delivery (Intramuscular, Subcutaneous, Intra Dermal)
- Statistical Snap of China Injectable Drug Delivery Devices Market
- Growth Analysis of China Injectable Drug Delivery Devices Market
- Problems and Challenges in China Injectable Drug Delivery Devices Market
- Competitive Landscape in the China Injectable Drug Delivery Devices Market
- Impact of COVID-19 and Demonetization on China Injectable Drug Delivery Devices Market
- Details on Recent Investment in China Injectable Drug Delivery Devices Market
- Competitive Analysis of China Injectable Drug Delivery Devices Market
- Major Players in the China Injectable Drug Delivery Devices Market
- SWOT Analysis of China Injectable Drug Delivery Devices Market
- China Injectable Drug Delivery Devices Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the China Injectable Drug Delivery Devices Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 China Injectable Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type
6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in China Injectable Drug Delivery Devices Market
7. China Injectable Drug Delivery Devices Market, By Type of Devices, 2019-2032 (USD Million)
7.1. Conventional Injection Devices
7.2. Self-Injection Devices
8. China Injectable Drug Delivery Devices Market, By Therapeutic Application, 2019-2032 (USD Million)
8.1. Autoimmune Diseases
8.2. Hormonal Disorders
8.3. Cancer
9. China Injectable Drug Delivery Devices Market, By Usage Pattern, 2019-2032 (USD Million)
9.1. Curative pattern
9.2. Immunization
10. China Injectable Drug Delivery Devices Market, By Site of Delivery, 2019-2032 (USD Million)
10.1. Intramuscular
10.2. Subcutaneous
10.3. Intra Dermal
11. China Injectable Drug Delivery Devices Market, By Region, 2019-2032 (USD Million)
11.1. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2019-2025)
11.2. China Injectable Drug Delivery Devices Market Size and Market Share by Region (2026-2032)
11.3. North China
11.4. Northeast China
11.5. East China
11.6. South China 
11.7. Central China
11.8. Southwest China
11.9. Northwest China
12. Company Profiles
12.1. Baxter
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Becton
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Dickinson and Company
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. F. Hoffmann-La Roche AG
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Gerresheimer AG
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. GSK plc
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Merck & Co. Inc.
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Novartis AG
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Pfizer Inc.
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Sanofi
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Teva Pharmaceutical Industries Ltd
12.11.1. Company details
12.11.2. Financial outlook
12.11.3. Product summary
12.11.4. Recent developments
13. List of Abbreviations
14. Reference Links
15. Conclusion
16. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
